Liraglutide ameliorates TAC-induced cardiac hypertrophy and heart failure by upregulating expression level of ANP expression

Recent studies have underscored the cardioprotective properties of liraglutide. This research explores its impact on cardiac hypertrophy and heart failure following transverse aortic constriction (TAC). We found that liraglutide administration markedly ameliorated cardiac hypertrophy, fibrosis, and...

Полное описание

Библиографические подробности

Главные авторы:	Ruisha Li, Keyin Zhang, Zhenjun Xu, Yanrong Yu, Dongjin Wang, Kai Li, Wenxue Liu, Jun Pan
Формат:	Artigo
Язык:	Inglês
Опубликовано:	Elsevier 2024-06-01
Серии:	Heliyon
Предметы:	Liraglutide Cardiac hypertrophy Heart failure ANP ER stress Apoptosis
Online-ссылка:	http://www.sciencedirect.com/science/article/pii/S2405844024082604
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!